These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7735515)

  • 1. Specific hyposensitization in patients allergic to Parietaria officinalis pollen allergen.
    Cvitanović S; Zekan L; Capkun V; Marusić M
    J Investig Allergol Clin Immunol; 1994; 4(6):283-90. PubMed ID: 7735515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergy to Parietaria officinalis pollen.
    Cvitanović S
    Croat Med J; 1999 Mar; 40(1):42-8. PubMed ID: 9933896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hyposensitization for tree pollinosis on associated apple allergy.
    Herrmann D; Henzgen M; Frank E; Rudeschko O; Jäger L
    J Investig Allergol Clin Immunol; 1995; 5(5):259-67. PubMed ID: 8574432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Specific skin reactions induced by individual pollen preparations in hypersensitivity persons].
    Paranos S; Petrović S; Vojović I
    Srp Arh Celok Lek; 1998; 126(9-10):362-7. PubMed ID: 9863408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin E and G antibody profiles to grass pollen allergens during a short course of sublingual immunotherapy.
    Aberer W; Hawranek T; Reider N; Schuster C; Sturm G; Kränke B
    J Investig Allergol Clin Immunol; 2007; 17(3):131-6. PubMed ID: 17583098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Skin reactivity in the histamine-equivalent skin test in hypersensitivity to grass pollen].
    Paranos S; Petrović S; Bojović I
    Srp Arh Celok Lek; 2000; 128(5-6):194-9. PubMed ID: 11089421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
    Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
    Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyposensitization therapy of Parietaria-sensitive patients with a tyrosine adsorbed allergoid, Pollinex Parietaria (Bencard Parietaria).
    Bonifazi F; Antonicelli L; Bilò MB; Pucci S; Taylor IH; Wheeler AW; Youlten LJ
    J Investig Allergol Clin Immunol; 1991 Feb; 1(1):37-44. PubMed ID: 1669563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
    Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
    J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.
    González-Rioja R; Ibarrola I; Arilla MC; Ferrer A; Mir A; Andreu C; Martínez A; Asturias JA
    J Allergy Clin Immunol; 2007 Sep; 120(3):602-9. PubMed ID: 17561242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy with a mass unit Parietaria judaica extract: a tolerance study with evidence of immunological changes to the major allergen Par j 1.
    García Villalmanzo I; Hernández MD; Campos A; Giner AM; Polo F; Cortés C; Basomba A
    J Investig Allergol Clin Immunol; 1999; 9(5):321-9. PubMed ID: 10582201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hybrid expressing genetically engineered major allergens of the Parietaria pollen as a tool for specific allergy vaccination.
    Bonura A; Corinti S; Artale A; Di Felice G; Amoroso S; Melis M; Geraci D; Colombo P
    Int Arch Allergy Immunol; 2007; 142(4):274-84. PubMed ID: 17124429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study.
    Klimek L; Schendzielorz P; Pinol R; Pfaar O
    Clin Exp Allergy; 2012 Jun; 42(6):936-45. PubMed ID: 22909165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interleukin 4, total and allergen-specific immunoglobulin E antibodies in the blood of individuals with an atopic constitution].
    Paranos S; Pravica V; Bonaci B; Stojković-Mostarica M
    Srp Arh Celok Lek; 1998; 126(3-4):92-6. PubMed ID: 9863362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.